Details:
Under the agreement, R-PHARM US has appointed Vector Pharma as exclusive distributor to import, use, market, sell and distribute Ixempra (ixabepilone) in the Middle East & North African territories.
Lead Product(s): Ixabepilone,Capecitabine
Therapeutic Area: Oncology Product Name: Ixempra
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: R-Pharm
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement December 22, 2021